Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taitsuko Ointment is an over-the-counter (OTC) Kampo herbal formulation developed and marketed by Melsmon Pharmaceutical in Japan. It is a topical treatment derived from traditional Chinese medicine principles, primarily used for skin conditions such as cuts, burns, abrasions, eczema, and hemorrhoids. The formulation typically contains a blend of botanical extracts known for their anti-inflammatory, analgesic, and wound-healing properties. As a Kampo medicine, it focuses on promoting natural healing processes of the skin and is recognized for its safety profile in treating minor dermatological injuries and irritations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Taitsuko Ointment.